Osteopontin as a biomarker for diagnosing the severity of osteoarthritis

Osteoarthritis (OA) is the most common type of arthritis. It is characterized by the loss of cartilage and pain ultimately leading to difficulty in movement. Glycoprotein osteopontin (OPN) is an essential regulator that plays a critical role in developing osteoarthritis. The study aims to determine...

Full description

Saved in:
Bibliographic Details
Main Authors: M. A. Taha, Z. M. A. A. Hamodat
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2024-10-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2024/10/Taha_96_5.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850137089382809600
author M. A. Taha
Z. M. A. A. Hamodat
author_facet M. A. Taha
Z. M. A. A. Hamodat
author_sort M. A. Taha
collection DOAJ
description Osteoarthritis (OA) is the most common type of arthritis. It is characterized by the loss of cartilage and pain ultimately leading to difficulty in movement. Glycoprotein osteopontin (OPN) is an essential regulator that plays a critical role in developing osteoarthritis. The study aims to determine the level of OPN in the serum of patients with OA and its correlation with the content of calcium (Ca), phosphorus (P), and magnesium (Mg). The study was conducted on 92 male and female patients aged between 30 and 65, categorized into mild, moderate, and severe groups through clinical examination and X-rays. The control group consist of 58 healthy males and females 30-65-year old. OPN was measured using the ELISA technique, and minerals were estimated using spectrophotometry. It was shown that in OA patients, OPN level increased highly significant when compared with the control group (10.7 ± 3.4 ng/ml) and depended on OA severity. In patients with severe OA, it was higher (47.5 ± 8.1 ng/ml) than in groups with moderate (14.8 ± 4.5 ng/ml) and mild (12.1 ± 3.1 ng/ml) extent of the disease. We showed a significant positive relationship between OPN and phosphorus levels and a negative significant correlation between OPN and calcium, calcium/phosphorus ratio, and magnesium. These findings underscore the potential of OPN as a valuable biomarker for diagnosing the severity of osteoarthritis and monitoring the effectiveness of treatment.
format Article
id doaj-art-bef2f13c28c54ea58016c09ca6529a43
institution OA Journals
issn 2409-4943
2413-5003
language English
publishDate 2024-10-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj-art-bef2f13c28c54ea58016c09ca6529a432025-08-20T02:30:56ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032024-10-01965313710.15407/ubj96.05.031Osteopontin as a biomarker for diagnosing the severity of osteoarthritisM. A. Taha0Z. M. A. A. Hamodat1Department of Chemistry, College of Science, University of Mosul, IraqDepartment of Chemistry, College of Science, University of Mosul, IraqOsteoarthritis (OA) is the most common type of arthritis. It is characterized by the loss of cartilage and pain ultimately leading to difficulty in movement. Glycoprotein osteopontin (OPN) is an essential regulator that plays a critical role in developing osteoarthritis. The study aims to determine the level of OPN in the serum of patients with OA and its correlation with the content of calcium (Ca), phosphorus (P), and magnesium (Mg). The study was conducted on 92 male and female patients aged between 30 and 65, categorized into mild, moderate, and severe groups through clinical examination and X-rays. The control group consist of 58 healthy males and females 30-65-year old. OPN was measured using the ELISA technique, and minerals were estimated using spectrophotometry. It was shown that in OA patients, OPN level increased highly significant when compared with the control group (10.7 ± 3.4 ng/ml) and depended on OA severity. In patients with severe OA, it was higher (47.5 ± 8.1 ng/ml) than in groups with moderate (14.8 ± 4.5 ng/ml) and mild (12.1 ± 3.1 ng/ml) extent of the disease. We showed a significant positive relationship between OPN and phosphorus levels and a negative significant correlation between OPN and calcium, calcium/phosphorus ratio, and magnesium. These findings underscore the potential of OPN as a valuable biomarker for diagnosing the severity of osteoarthritis and monitoring the effectiveness of treatment.http://ukrbiochemjournal.org/wp-content/uploads/2024/10/Taha_96_5.pdfcalciummagnesiumosteoarthritisosteopontinphosphorus
spellingShingle M. A. Taha
Z. M. A. A. Hamodat
Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
The Ukrainian Biochemical Journal
calcium
magnesium
osteoarthritis
osteopontin
phosphorus
title Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
title_full Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
title_fullStr Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
title_full_unstemmed Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
title_short Osteopontin as a biomarker for diagnosing the severity of osteoarthritis
title_sort osteopontin as a biomarker for diagnosing the severity of osteoarthritis
topic calcium
magnesium
osteoarthritis
osteopontin
phosphorus
url http://ukrbiochemjournal.org/wp-content/uploads/2024/10/Taha_96_5.pdf
work_keys_str_mv AT mataha osteopontinasabiomarkerfordiagnosingtheseverityofosteoarthritis
AT zmaahamodat osteopontinasabiomarkerfordiagnosingtheseverityofosteoarthritis